Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

Australian scientists discover new virus in bats

Australian scientists have discovered a new virus in bats that could help shed light on how Hendra and Nipah viruses cause disease and death in animals and humans. The new virus - named 'Cedar' after the Queensland location where it was discovered - is a close relative of the deadly Hendra and Nipah viruses.

3 Aug 2012

Number of suspected Ebola cases in Uganda rises to 36; Outbreak has killed 14

The number of confirmed or suspected cases of Ebola in Uganda has risen to 36, according to a WHO spokesperson, who added the disease remains confined to the rural Kibaale district, NPR's health blog "Shots" reports.

2 Aug 2012

Médecins Sans Frontières help fight Ebola outbreak in Uganda

An emergency team from the international medical humanitarian organisation Médecins Sans Frontières is in Kigadi, in western Uganda’s Kibaale district, to help fight an outbreak of the Ebola virus. Other Médecins Sans Frontières teams in Uganda are closely monitoring the situation.

1 Aug 2012

Ebola outbreak identified in Uganda

"The world's first major outbreak of Ebola hemorrhagic fever since 2009 has killed at least 14 of 20 people infected in a remote area of midwestern Uganda," the Wall Street Journal reports (Bariyo/McKay, 7/29).

30 Jul 2012

UTMB researchers receives NIH grant to develop engineered lung tissue for biomedical studies

University of Texas Medical Branch at Galveston researchers have been awarded a two-year, $1.25 million National Institutes of Health grant to develop a method of custom-growing human lung tissue to make a three-dimensional model for biomedical studies.

30 Jul 2012

Rutgers cell biologist to receive Presidential Early Career Award for Scientists and Engineers

Fewer than 100 researchers nationwide are chosen each year to receive the Presidential Early Career Award for Scientists and Engineers (PECASE), and this year Dr. Nihal Altan-Bonnet is one of the 96 to receive this honor.

25 Jul 2012

Researchers discover bats as reservoir of infections

Measles, mumps, pneumonia, influenza and encephalitis in man, Carré's disease in dogs, Ovine Rinderpest (PPR)… all of these diseases are caused by viruses from the same family: Paramyxoviridae. A vast international study, carried out in collaboration with IRD researchers and published in Nature communications has led to the discovery of more than 60 new species of these dangerous infectious agents, almost double the number previously recorded. This family of highly diverse pathogens affects all animals, from canines to fowl, cattle and humans.

25 Jul 2012

Einstein researchers to study molecular mechanism behind Ebola virus infection

The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine of Yeshiva University a five-year, $4.8 million grant to study the molecular mechanism that allows the Ebola virus to cause infection and spread in animals.

10 Jul 2012

Researchers use clever screening methods to speed vaccine production

Infectious diseases-both old and new-continue to exact a devastating toll, causing some 13 million fatalities per year around the world. Vaccines remain the best line of defense against deadly pathogens and now Kathryn Sykes and Stephen Johnston, researchers at Arizona State University's Biodesign Institute, along with co-author Michael McGuire from the University of Texas Southwestern Medical Center are using clever functional screening methods to attempt to speed new vaccines into production that are both safer and more potent.

10 May 2012

Antibody-based therapies successfully protect monkeys from deadly Ebola and Marburg viruses

Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date.

14 Mar 2012

Paragon receives JVAP-CBMS contract from DoD

Paragon Bioservices, Inc., a Baltimore-based CMO focused on the process development and manufacturing of biologics, announced today that it has been awarded a JVAP-CBMS contract from the Department of Defense (DoD) for the vaccine development and subsequent GMP manufacturing of the "VEE Replicon Particle Trivalent Filovirus Vaccine."

18 Jan 2012

Anthrax defenses need to be strengthened say experts

It has been a decade since the anthrax attacks brought home the reality of bioterrorism and the nation has a stockpile of some basic tools to fight back against a few of the threats that worry defense experts the most.

8 Jan 2012

BBC News Magazine examines antiviral drug research

BBC News Magazine examines an antiviral drug called Draco, developed by Todd Rider, a research scientist at the Massachusetts Institute of Technology, "which has proven successful against all 15 viruses to which it has been applied in lab trials with human tissue and mice," including "the common cold, H1N1 or swine flu, a polio virus, dengue fever, and the notorious and fatal Ebola virus."

23 Dec 2011

UC Davis professor monitors world's hot spots for signs of emerging diseases

It's not a matter of if a worldwide pandemic will strike but when, say experts like veterinarian and epidemiologist Jonna Mazet, a professor in the Department of Medicine and Epidemiology in the University of California, Davis, School of Veterinary Medicine. That's why Mazet, who leads an early warning pandemic system called PREDICT, monitors the world's hot spots, or "hot interfaces" for signs of emerging diseases.

21 Dec 2011

Vaccine against Ebola developed

Ebola was first identified in 1976 in Sudan and Zaire, which is now the Democratic Republic of the Congo and Ebola fever kills more than 90% of the people it infects. Ebola is among the most lethal diseases known to humans, according to the World Health Organization.

7 Dec 2011

Scientists isolate and analyze antibody that neutralizes Sudan virus

Scientists from The Scripps Research Institute and the US Army's Medical Research Institute of Infectious Diseases have isolated and analyzed an antibody that neutralizes Sudan virus, a major species of ebolavirus and one of the most dangerous human pathogens.

20 Nov 2011

DNA primer vaccine enhances immune response to H5N1 avian influenza vaccine

The immune response to an H5N1 avian influenza vaccine was greatly enhanced in healthy adults if they were first primed with a DNA vaccine expressing a gene for a key H5N1 protein, researchers say.

4 Oct 2011

Anthrax defenses need to be strengthened: Experts

It has been a decade since the anthrax attacks brought home the reality of bioterrorism and the nation now has a stockpile of some basic tools to fight back against a few of the threats that worry defense experts the most.

28 Sep 2011

Study may help explain plague's rapid evolution and aid in development of therapeutics

In the evolutionary blink of an eye, a bacterium that causes mild stomach irritation evolved into a deadly assassin responsible for the most devastating pandemics in human history. How did the mild-mannered Yersinia pseudotuberculosis become Yersinia pestis, more commonly known as the Plague?

30 Aug 2011

Black Death bacteria may be extinct - Study

The bacteria that caused the Black Death or plague, which wiped out millions in mid-14th century Europe, may be extinct, according to a new study. The Black Death claimed the lives of one-third of Europeans in just five years from 1348 to 1353. Until recently, it was not certain whether the bacterium Yersinia pestis - known to cause the plague today - was responsible for that most deadly outbreak of disease ever. Now, the University of Tübingen's Institute of Scientific Archaeology and McMaster University in Canada have been able to confirm that Yersinia pestis was behind the great plague.

30 Aug 2011